Navigation Links
Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell

eriments showed gene activity was limited to pancreatic cancer cells and was minimal or absent from other cancers and three lines of normal pancreatic, lung and breast cells.

The next step was to load the vector with a weapon. The team packaged its mutant version of the Bik gene along with C-VISA in a liposome. For comparison, the liposomal gene also was attached to the CMV vector.

They tested both systems in the lab against all 13 available human cell lines of pancreatic cancer available worldwide. BikDD killed cells in all lines, with the VISA-delivered gene destroying more cells in all but one case. The C-VISA system spared healthy tissue while CMV-BikDD destroyed healthy cells. Subsequent tests compared the two methods in the mouse models.

Hung's team continues research on gene expression vehicle. "VISA is versatile enough that if you change the promoter, you could target other cancers or even other diseases," Hung says.

Research was funded by Abbruzzese's pancreatic cancer SPORE grant from the NCI, M. D. Anderson's NCI center support grant, a grant from the Topfer Research Funds, and an AstraZeneca Fellowship.

M. D. Anderson has filed for a patent on VISA-BikDD, which has been licensed to Alchemgen Therapeutics Inc. (ATI). ATI partially supports Hung's research. Hung and M. D. Anderson own stock in the company. These arrangements are managed by M. D. Anderson in accordance with its conflict of interest policies.

Co-authors of the Cancer Cell paper with Hung, Abbruzzese and Xie are: Weiya Xia, Hsu-Ping Kuo, Yuanfang Liu, Zheng Li, Qingqing Ding, Su Zhang, Bill Spohn, Yan Yang, Yongkun Wei, and Jing-Yu Lang, all of the Department of Molecular and Cellular Oncology; and Zhongkui Li, Douglas B. Evans, and Paul J. Chiao, all of the Department of Surgical Oncology. Kuo and Hung also are affiliated with the Graduate School of Biomedical Sciences, operated jointly by M. D. Anderson and The University of Texas Health Science Cen
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
5. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
6. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
7. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
8. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
9. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
Post Your Comments:
(Date:4/17/2015)... 2015 Sigma-Aldrich Corporation (NASDAQ: ... High Technology company, today announced the opening of ... and state-of-the-art Cell Culture Technical Center in Singapore.  ... provide customized support to meet customer needs, leveraging ... "Our new Technical Center will significantly enhance our ...
(Date:4/17/2015)... , April 17, 2015 TWi Pharmaceuticals, Inc. ... TWi Pharmaceuticals USA , has obtained ... United States.  It has been in close contact with ... expects to have its own label specialty generic products ... the U.S. pharma market. According to IMS ...
(Date:4/16/2015)... SHENZHEN, China , April 16, 2015 /PRNewswire/ ... a leading developer, manufacturer, and marketer of medical ... with the Securities and Exchange Commission an Annual Report ... for the year ended December 31, 2014. An electronic ... is available on Mindray,s investor relations website at  ...
Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
... Verenium Corporation (Nasdaq: VRNM ), a ... solutions, today announced a series of changes within its senior ... Carlos Riva, currently Director, President and Chief Executive Officer, will ... continue to be available to the Company as a consultant ...
... MOUNTAIN VIEW, Calif., Feb. 25, 2011 VIVUS, Inc. ... Morris, chief financial officer, will present an overview of ... of March.  The conference presentation schedule is as follows:Citi,s ... p.m. ETHilton New York Hotel, New York, NYCowen and ...
Cached Medicine Technology:Verenium Announces Changes in Senior Management 2Verenium Announces Changes in Senior Management 3
(Date:4/17/2015)... As a board-certified orthopedic surgeon, Dr. Steven ... platelet-rich plasma (PRP) and stem cell therapy. ... for its world-class care of injury-caused and chronic joint ... in many other physicians offering regenerative medicines. , ... pain management and rehabilitation. Dr. Meier and MOSM can ...
(Date:4/17/2015)... Baptist Health and The University of Texas ... designed to transform oncology care in northeast Florida and ... create a joint cancer program to enhance patient access ... MD Anderson Cancer Center is anticipated to open in ... highly coordinated, multidisciplinary cancer care for adults in the ...
(Date:4/17/2015)... Connie Casad, M.D., a well-known and respected ... 30 years of practice experience in Dallas, Texas, has ... service for her patients with the availability of a ... books with a brief synopsis on each for her ... in providing this service, Dr. Casad said, “Furnishing a ...
(Date:4/17/2015)... NJ (PRWEB) April 17, 2015 ... in the posterior pituitary and thought to help mothers ... between couples. To further substantiate this, new studies performed, ... the journal, Nature, and reported by Medical News Today ... a powerful influence over maternal social behavior. The study ...
(Date:4/17/2015)... 2015 Ticket Down is a reputable source of ... Tour. , The life of last-minute show announcements is where fans ... perform during the early part of 2015, but beginning in June, ... Lion Man,” “The Cave,” and “Believe,” will perform a full-fledged tour ... at MCU Park at Coney Island in Brooklyn, NY and ends ...
Breaking Medicine News(10 mins):Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3Health News:Mumford and Sons Tickets in Clarkston/Detroit, Raleigh, Columbia/Baltimore, Chicago, Mansfield/Boston, Brooklyn, Calgary and Edmonton Now On Sale 2
... N.J. and MONTVALE, N.J., Nov. 25 Roche and ... that the two companies have signed a definitive merger ... of Memory Pharmaceuticals in an all-cash transaction for an ... , Memory Pharmaceuticals develops ...
... Vitech Systems Group, Inc. (Vitech) has completed phase ... the Iowa Public Employees, Retirement System (IPERS). IPERS, one ... contracted with Vitech in 2006 to implement and maintain ... capabilities and increases efficiency, transforming IPERS, business. , ...
... PhD student, Dr Sue Lynn Lau, had won the Graduate ... PhD" contest. See her winning entry on YouTube. , On ... world to interpret their PhD research in dance form, film ... by mid-November. A total of 36 dances - including ...
... 2008 Forest Laboratories, Inc. (NYSE: FRX ) ... has closed prosecution on the merits of the reexamination proceedings ... all of the previously granted claims. As a result, the ... Parte Reexamination Certificate for U.S. Patent No. 6,545,040 (the ,040 ...
... receptor cuts the urge for nicotine, rat study suggests , , ... in the brain may be one way to quickly lessen ... Hypocretin-1, or Orexin A, a short chain of amino acids ... closely linked biochemical reactions that makes lab rats crave nicotine, ...
... with an impermeable sleeve led to both weight loss ... model of obesity-induced diabetes. Investigators from the Massachusetts ... in the journal Obesity that the procedure ... a significant reduction in the animals, food intake and ...
Cached Medicine News:Health News:Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals 2Health News:Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals 3Health News:Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals 4Health News:Vitech's V3 Pension Administration Software Improves IPERS' Business 2Health News:Ph.D. student Sue Lynn Lau dances her way to Chicago 2Health News:USPTO Confirms Validity of Bystolic(R) Patent 2Health News:Molecular Switch in Brain May End Smokers' Cravings 2Health News:Sealing off portion of intestinal lining treats obesity, resolves diabetes in animal model 2Health News:Sealing off portion of intestinal lining treats obesity, resolves diabetes in animal model 3
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
... The Vibratome Roto-Shake Genie is an ... It performs five different mixing ... and rotating/rolling, as well as a ... The precision-engineered moving portion of the ...
... The Vibratome Roto-Shake Genie is ... platform. It performs five different ... rolling/rocking and rotating/rolling, as well as ... The precision-engineered moving portion of ...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Medicine Products: